A simple approximation for the evaluation of the photon iso-effective dose in Boron Neutron Capture Therapy based on dose-independent weighting factors.


Journal

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine
ISSN: 1872-9800
Titre abrégé: Appl Radiat Isot
Pays: England
ID NLM: 9306253

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 22 05 2019
revised: 27 11 2019
accepted: 03 12 2019
pubmed: 1 1 2020
medline: 15 12 2020
entrez: 1 1 2020
Statut: ppublish

Résumé

The current methodology for determining the biological effect of Boron Neutron Capture Therapy (BNCT) has recently been questioned, and a more accurate framework based in the photon iso-effective dose has been proposed. In this work we derive a first order approximation to this quantity. The new approach removes the main drawbacks of the current method, being based on new weighting factors which are true constants (dose independent) but which can be evaluated from published data on the existing (dose-dependent) weighting factors. In addition to this, we apply the formalism to allow the comparison to a fractionated conventional radiotherapy treatment, for which there is a lot of knowledge from clinical practice. As an application, the photon iso-effective dose of a BNCT treatment for a brain tumor is estimated. An excel sheet used for these calculations is also provided as supplementary material and can be used also with user-provided input data for the estimation of the photon iso-effective dose for comparison with conventional radiotherapy, both to single and fractionated treatments.

Identifiants

pubmed: 31889683
pii: S0969-8043(19)30542-1
doi: 10.1016/j.apradiso.2019.109018
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

109018

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare no conflict of interest for this work.

Auteurs

María Pedrosa-Rivera (M)

Departamento de Física Atómica, Molecular y Nuclear, Universidad de Granada, Granada, Spain; Institut Laue-Langevin. Grenoble, Rhône-Alpes, France.

Javier Praena (J)

Departamento de Física Atómica, Molecular y Nuclear, Universidad de Granada, Granada, Spain.

Ignacio Porras (I)

Departamento de Física Atómica, Molecular y Nuclear, Universidad de Granada, Granada, Spain. Electronic address: porras@ugr.es.

María José Ruiz-Magaña (MJ)

Departamento de Bioquímica y Biología Molecular III e Inmunología, Universidad de Granada, Granada, Spain.

Carmen Ruiz-Ruiz (C)

Departamento de Bioquímica y Biología Molecular III e Inmunología, Universidad de Granada, Granada, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH